Santé log

Koelis Announces Innovative Products at EAU 2026 enhancing MRI Fusion Biopsy Workflows and promoting Focal Therapy in Prostate Cancer

Prof. Nicolas Barry-Delongchamps, Professor of Urology at Cochin Hospital and Principal Investigator of the VIOLETTE trial, will present the final results and one-year patients follow-up from the ...
ascopubs.org

MRI-targeted biopsy with index lesion ipsilateral or bilateral systematic biopsy in prostate cancer: A multicenter, paired, noninferiority, observational trial.

Role of urinary exosomal FAM153C-RPL19 in detection and risk stratification of prostate cancer: A multicentre Chinese cohort study. This is an ASCO Meeting Abstract from the 2026 ASCO Genitourinary ...
ascopubs.org

Comparison of multiparametric prostate MRI (mpMRI) vs. positive biopsy cores on risk of adverse pathologic outcomes after radical prostatectomy (RP) in Gleason grade group (GG ...

The clinical impact of germline variants in DNA repair genes in patients who underwent curative surgery for localized prostate cancer. Multivariable logistic regression model for predicting ...

Profound Medical Corp. (PRN:CA) Discusses First Clinical Outcomes and Precision of TULSA from the CAPTAIN Trial in Prostate Cancer Transcript

Discusses First Clinical Outcomes and Precision of TULSA from the CAPTAIN Trial in Prostate Cancer March 13, 2026 11:30 ...